Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Prognostic factor of poor outcome in anti-MAG neuropathy: clinical and electrophysiological analysis of a French Cohort.

Tang MH, Mathis S, Duffau P, Cazenave P, Solé G, Duval F, Soulages A, Le Masson G.

J Neurol. 2019 Nov 8. doi: 10.1007/s00415-019-09618-0. [Epub ahead of print]

PMID:
31705291
2.

Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts.

Ruiz-Irastorza G, Ruiz-Estevez B, Lazaro E, Ruiz-Arruza I, Duffau P, Martin-Cascon M, Richez C, Ugarte A, Blanco P.

Autoimmun Rev. 2019 Sep;18(9):102359. doi: 10.1016/j.autrev.2019.102359. Epub 2019 Jul 16.

PMID:
31323362
3.

Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.

Brilland B, Scherlinger M, Khoryati L, Goret J, Duffau P, Lazaro E, Charrier M, Guillotin V, Richez C, Blanco P.

Clin Rev Allergy Immunol. 2019 Jun 28. doi: 10.1007/s12016-019-08744-x. [Epub ahead of print] Review.

PMID:
31254159
4.

Atypical Presentation of Bacteremia in Older Patients Is a Risk Factor for Death.

Hyernard C, Breining A, Duc S, Kobeh D, Dubos M, Prevel R, Cazanave C, Lambert M, Bonnet F, Mercie P, Contis A, Duffau P, Camou F, Guerville F, Rainfray M, Roubaud-Baudron C.

Am J Med. 2019 Nov;132(11):1344-1352.e1. doi: 10.1016/j.amjmed.2019.04.049. Epub 2019 Jun 1.

PMID:
31163127
5.

Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study.

Scherlinger M, Carcaud C, Truchetet ME, Barnetche T, Duffau P, Couzi L, Seneschal J, Blanco P, Lazaro E, Richez C.

Ann Rheum Dis. 2019 Jul;78(7):1007-1010. doi: 10.1136/annrheumdis-2018-214833. Epub 2019 Jan 4. No abstract available.

PMID:
30610064
6.

OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Jacquemin C, Augusto JF, Scherlinger M, Gensous N, Forcade E, Douchet I, Levionnois E, Richez C, Lazaro E, Duffau P, Truchetet ME, Seneschal J, Couzi L, Pellegrin JL, Viallard JF, Schaeverbeke T, Pascual V, Contin-Bordes C, Blanco P.

JCI Insight. 2018 Dec 20;3(24). pii: 122167. doi: 10.1172/jci.insight.122167.

7.

[Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].

Victor J, Zanardo L, Héron-Mermin D, Poursac N, Solé G, Bordes C, Duffau P.

Rev Med Interne. 2019 Feb;40(2):70-81. doi: 10.1016/j.revmed.2018.11.003. Epub 2018 Dec 4. French.

PMID:
30527961
8.

[Biosimilars in France, to understand the stakes in order to use them well].

Scherlinger M, Pellegrin JL, Germain V, Lazaro E, Duffau P, Schaeverbeke T; FHU ACRONIM.

Rev Med Interne. 2019 Jan;40(1):5-8. doi: 10.1016/j.revmed.2018.10.383. Epub 2018 Nov 3. French. No abstract available.

PMID:
30396704
9.

Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances.

Laurent P, Sisirak V, Lazaro E, Richez C, Duffau P, Blanco P, Truchetet ME, Contin-Bordes C.

Front Immunol. 2018 Jul 23;9:1702. doi: 10.3389/fimmu.2018.01702. eCollection 2018. Review.

10.

T Follicular Helper Cells in Autoimmune Disorders.

Gensous N, Charrier M, Duluc D, Contin-Bordes C, Truchetet ME, Lazaro E, Duffau P, Blanco P, Richez C.

Front Immunol. 2018 Jul 17;9:1637. doi: 10.3389/fimmu.2018.01637. eCollection 2018. Review.

11.

Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms.

Lapoirie J, Contis A, Guy A, Lifermann F, Viallard JF, Sentilhes L, James C, Duffau P.

J Matern Fetal Neonatal Med. 2020 Jan;33(1):49-56. doi: 10.1080/14767058.2018.1484097. Epub 2018 Jun 26.

PMID:
29945475
12.

Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis.

Meunier P, Dequidt L, Barnetche T, Lazaro E, Duffau P, Richez C, Couzi L, Truchetet ME, Seneschal J; FHU ACRONIM.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):405-409. doi: 10.1111/jdv.15114. Epub 2018 Jul 17.

PMID:
29888406
13.

Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.

Duffau P, Ozanne A, Bonnet F, Lazaro E, Cazanave C, Blanco P, Rivière E, Desclaux A, Hyernard C, Gensous N, Pellegrin I, Wittkop L.

AIDS. 2018 Jul 31;32(12):1651-1660. doi: 10.1097/QAD.0000000000001875.

PMID:
29762168
14.

Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets.

Scherlinger M, Guillotin V, Truchetet ME, Contin-Bordes C, Sisirak V, Duffau P, Lazaro E, Richez C, Blanco P.

Autoimmun Rev. 2018 Jun;17(6):625-635. doi: 10.1016/j.autrev.2018.01.012. Epub 2018 Apr 7. Review.

PMID:
29635077
15.

Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis.

Guillotin V, Bouhet A, Barnetche T, Richez C, Truchetet ME, Seneschal J, Duffau P, Lazaro E; Fédération Hospitalo-Universitaire Acronim.

Joint Bone Spine. 2018 Dec;85(6):663-668. doi: 10.1016/j.jbspin.2018.03.006. Epub 2018 Apr 6.

PMID:
29631068
16.

Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases.

Baulier G, Issa N, Gabriel F, Accoceberry I, Camou F, Duffau P.

Clin Exp Rheumatol. 2018 May-Jun;36(3):490-493. Epub 2018 Feb 26.

PMID:
29533748
17.

Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis.

Henrot P, Foret J, Barnetche T, Lazaro E, Duffau P, Seneschal J, Schaeverbeke T, Truchetet ME, Richez C.

Joint Bone Spine. 2018 Mar;85(2):155-163. doi: 10.1016/j.jbspin.2017.12.009. Epub 2017 Dec 27.

PMID:
29288864
18.

Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients.

Guilhem A, Fargeton AE, Simon AC, Duffau P, Harle JR, Lavigne C, Carette MF, Bletry O, Kaminsky P, Leguy V, Lerolle N, Roux D, Lambert M, Chinet T, Bonnet D, Dupuis-Girod S, Rivière S.

PLoS One. 2017 Nov 30;12(11):e0188943. doi: 10.1371/journal.pone.0188943. eCollection 2017.

19.

Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.

Thiébaut R, Hue S, Le Marec F, Lelièvre JD, Dupon M, Foucat E, Lazaro E, Dabis F, Duffau P, Wittkop L, Surenaud M, Pellegrin I, Lacabaratz C, Bonnet F, Lévy Y; ANRS CO3 Aquitaine Cohort.

AIDS. 2017 Nov 13;31(17):2355-2365. doi: 10.1097/QAD.0000000000001628.

PMID:
29068834
20.

Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review.

Gensous N, Marti A, Barnetche T, Blanco P, Lazaro E, Seneschal J, Truchetet ME, Duffau P, Richez C; FHU ACRONIM.

Arthritis Res Ther. 2017 Oct 24;19(1):238. doi: 10.1186/s13075-017-1442-6. Review.

21.

Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.

Eyraud A, Scouppe L, Barnetche T, Forcade E, Lazaro E, Duffau P, Richez C, Seneschal J, Truchetet ME; FHU ACRONIM.

Br J Dermatol. 2018 Mar;178(3):650-658. doi: 10.1111/bjd.15993. Epub 2018 Feb 1.

PMID:
28906550
22.

New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Scherlinger M, Sisirak V, Richez C, Lazaro E, Duffau P, Blanco P.

Curr Rheumatol Rep. 2017 Aug;19(8):48. doi: 10.1007/s11926-017-0678-0. Review.

PMID:
28718063
23.

[Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France].

Biscay P, Ralazamahaleo M, Lazaro E, Richez C, Seneschal J, Rigothier C, Contin-Bordes C, Duffau P.

Rev Med Interne. 2017 Oct;38(10):656-662. doi: 10.1016/j.revmed.2017.06.003. Epub 2017 Jul 6. French.

PMID:
28690094
24.

Neutrophil-derived mitochondrial DNA promotes receptor activator of nuclear factor κB and its ligand signalling in rheumatoid arthritis.

Contis A, Mitrovic S, Lavie J, Douchet I, Lazaro E, Truchetet ME, Goizet C, Contin-Bordes C, Schaeverbeke T, Blanco P, Rossignol R, Faustin B, Richez C, Duffau P.

Rheumatology (Oxford). 2017 Jul 1;56(7):1200-1205. doi: 10.1093/rheumatology/kex041.

PMID:
28340056
25.

Activation, senescence and inflammation markers in HIV patients: association with renal function.

Ozanne A, Duffau P, Dauchy FA, Rigothier C, Terrien C, Lazaro E, Cazanave C, Lawson-Ayayi S, Bonnet F, Blanco P, Wittkop L, Pellegrin I; CIADIS sub-study in the ANRS CO3 Aquitaine cohort study group.

AIDS. 2017 May 15;31(8):1119-1128. doi: 10.1097/QAD.0000000000001461.

PMID:
28328797
26.

[Systemic lupus erythematosus and contraception: A systematic literature review].

Gensous N, Doassans-Comby L, Lazaro E, Duffau P.

Rev Med Interne. 2017 Jun;38(6):358-367. doi: 10.1016/j.revmed.2016.12.009. Epub 2017 Feb 1. Review. French.

PMID:
28161112
27.

Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.

Contis A, Gensous N, Viallard JF, Goizet C, Léauté-Labrèze C, Duffau P.

Clin Otolaryngol. 2017 Aug;42(4):911-917. doi: 10.1111/coa.12821. Epub 2017 Jan 20. No abstract available.

PMID:
28032956
28.

Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.

Truchetet ME, Demoures B, Eduardo Guimaraes J, Bertrand A, Laurent P, Jolivel V, Douchet I, Jacquemin C, Khoryati L, Duffau P, Lazaro E, Richez C, Seneschal J, Doutre MS, Pellegrin JL, Constans J, Schaeverbeke T, Blanco P, Contin-Bordes C; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2016 Nov;68(11):2784-2794. doi: 10.1002/art.39817. Epub 2016 Oct 9.

29.

Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis.

Pugès M, Biscay P, Barnetche T, Truchetet MÉ, Richez C, Seneschal J, Gensous N, Lazaro E, Duffau P.

Rheumatology (Oxford). 2016 Sep;55(9):1664-72. doi: 10.1093/rheumatology/kew211. Epub 2016 May 9. Review.

PMID:
27160278
30.

Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012.

Collin A, Le Marec F, Vandenhende MA, Lazaro E, Duffau P, Cazanave C, Gérard Y, Dabis F, Bruyand M, Bonnet F; ANRS CO3 Aquitaine Cohort Study Group.

PLoS One. 2016 Apr 6;11(4):e0152970. doi: 10.1371/journal.pone.0152970. eCollection 2016.

31.

IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.

Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2016 Sep;68(9):2221-31. doi: 10.1002/art.39679.

32.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

Durel CA, Aouba A, Bienvenu B, Deshayes S, Coppéré B, Gombert B, Acquaviva-Bourdain C, Hachulla E, Lecomte F, Touitou I, Ninet J, Philit JB, Messer L, Brouillard M, Girard-Madoux MH, Moutschen M, Raison-Peyron N, Hutin P, Duffau P, Trolliet P, Hatron PY, Heudier P, Cevallos R, Lequerré T, Brousse V, Lesire V, Audia S, Maucort-Boulch D, Cuisset L, Hot A.

Medicine (Baltimore). 2016 Mar;95(11):e3027. doi: 10.1097/MD.0000000000003027.

33.

Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.

Contis A, Vanquaethem H, Truchetet ME, Couzi L, Rigothier C, Richez C, Lazaro E, Duffau P.

Clin Rheumatol. 2016 Feb;35(2):517-22. doi: 10.1007/s10067-015-3166-9. Epub 2016 Jan 14.

PMID:
26762196
34.

Role of extracellular vesicles in autoimmune diseases.

Turpin D, Truchetet ME, Faustin B, Augusto JF, Contin-Bordes C, Brisson A, Blanco P, Duffau P.

Autoimmun Rev. 2016 Feb;15(2):174-83. doi: 10.1016/j.autrev.2015.11.004. Epub 2015 Nov 7. Review.

PMID:
26554931
35.

Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients.

Duffau P, Wittkop L, Lazaro E, le Marec F, Cognet C, Blanco P, Moreau JF, Dauchy FA, Cazanave C, Vandenhende MA, Bonnet F, Thiebaut R, Pellegrin I; ANRS CO3 Aquitaine Cohort Study Group.

AIDS. 2015 Oct 23;29(16):2099-108. doi: 10.1097/QAD.0000000000000807.

PMID:
26544576
36.

[Cough as the presenting feature of pulmonary AL amyloidosis: A case report].

Baulier G, Victor J, Mercié P, Lazaro E, Duffau P.

Rev Med Interne. 2016 May;37(5):363-6. doi: 10.1016/j.revmed.2015.08.008. Epub 2015 Sep 14. French.

PMID:
26383767
37.

Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.

Duffau P, Menn-Josephy H, Cuda CM, Dominguez S, Aprahamian TR, Watkins AA, Yasuda K, Monach P, Lafyatis R, Rice LM, Kenneth Haines G 3rd, Gravallese EM, Baum R, Richez C, Perlman H, Bonegio RG, Rifkin IR.

Arthritis Rheumatol. 2015 Dec;67(12):3146-57. doi: 10.1002/art.39321.

38.

Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study.

Houx L, Hachulla E, Kone-Paut I, Quartier P, Touitou I, Guennoc X, Grateau G, Hamidou M, Neven B, Berthelot JM, Lequerré T, Pillet P, Lemelle I, Fischbach M, Duquesne A, Le Blay P, Le Jeunne C, Stirnemann J, Bonnet C, Gaillard D, Alix L, Touraine R, Garcier F, Bedane C, Jurquet AL, Duffau P, Smail A, Frances C, Grall-Lerosey M, Cathebras P, Tran TA, Morell-Dubois S, Pagnier A, Richez C, Cuisset L, Devauchelle-Pensec V.

Arthritis Rheumatol. 2015 Nov;67(11):3027-36. doi: 10.1002/art.39292.

39.

OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, Maurouard T, Dougall D, Davizon ES, Dumortier H, Douchet I, Raffray L, Richez C, Lazaro E, Duffau P, Truchetet ME, Khoryati L, Mercié P, Couzi L, Merville P, Schaeverbeke T, Viallard JF, Pellegrin JL, Moreau JF, Muller S, Zurawski S, Coffman RL, Pascual V, Ueno H, Blanco P.

Immunity. 2015 Jun 16;42(6):1159-70. doi: 10.1016/j.immuni.2015.05.012. Epub 2015 Jun 9.

40.

Septic shock sera containing circulating histones induce dendritic cell-regulated necrosis in fatal septic shock patients.

Raffray L, Douchet I, Augusto JF, Youssef J, Contin-Bordes C, Richez C, Duffau P, Truchetet ME, Moreau JF, Cazanave C, Leroux L, Mourrissoux G, Camou F, Clouzeau B, Jeannin P, Delneste Y, Gabinski C, Guisset O, Lazaro E, Blanco P.

Crit Care Med. 2015 Apr;43(4):e107-16. doi: 10.1097/CCM.0000000000000879.

PMID:
25654179
41.

IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.

Watkins AA, Yasuda K, Wilson GE, Aprahamian T, Xie Y, Maganto-Garcia E, Shukla P, Oberlander L, Laskow B, Menn-Josephy H, Wu Y, Duffau P, Fried SK, Lichtman AH, Bonegio RG, Rifkin IR.

J Immunol. 2015 Feb 15;194(4):1467-79. doi: 10.4049/jimmunol.1402807. Epub 2015 Jan 16.

42.

[Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy].

Raffray L, Rivière P, Bonnet H, Duffau P, Longy-Boursier M.

Rev Med Interne. 2015 Sep;36(9):626-30. doi: 10.1016/j.revmed.2014.10.361. Epub 2014 Nov 18. French.

PMID:
25467298
43.

Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France.

Vareil MO, Rouibi G, Kassab S, Soula V, Duffau P, Lafon ME, Neau D, Cazanave C.

Med Mal Infect. 2014 Dec;44(11-12):502-8. doi: 10.1016/j.medmal.2014.09.006. Epub 2014 Oct 25.

PMID:
25391635
44.

Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways.

Ericson JA, Duffau P, Yasuda K, Ortiz-Lopez A, Rothamel K, Rifkin IR, Monach PA; ImmGen Consortium.

PLoS One. 2014 Oct 3;9(10):e108553. doi: 10.1371/journal.pone.0108553. eCollection 2014.

45.

[An exophtalmos].

Raffray L, Bertolotti A, Duffau P, Longueville E, Mercié P, Longy-Boursier M.

Presse Med. 2013 Dec;42(12):1674-7. doi: 10.1016/j.lpm.2013.03.014. Epub 2013 Oct 18. French. No abstract available.

PMID:
24144886
46.

[Chronic diarrhea in 43-year-old man].

Larcher R, Andrieu JM, Ramdani M, Passebois L, Favier L, Oziol E, Duffau P.

Rev Med Interne. 2013 Dec;34(12):780-2. doi: 10.1016/j.revmed.2013.06.010. Epub 2013 Sep 5. French. No abstract available.

PMID:
24011846
47.

[Large granular lymphocyte leukemia: clinical and pathogenic aspects].

Lazaro E, Duffau P, Chaigne Delalande S, Greib C, Pellegrin JL, Viallard JF.

Rev Med Interne. 2013 Sep;34(9):553-60. doi: 10.1016/j.revmed.2012.12.020. Epub 2013 Aug 5. Review. French.

PMID:
23928096
48.

Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.

Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, Déti E, Gerard Y, Lazaro E, Duffau P, Neau D, Bonnet F, Chêne G; Groupe D’epidémiologie Clinique du Sida en Aquitaine (Gecsa).

PLoS One. 2013 Jun 12;8(6):e66223. doi: 10.1371/journal.pone.0066223. Print 2013.

49.

Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.

d'Elbée JM, Parrens M, Mercié P, Longy Boursier M, Dieval C, de Mascarel A, Duffau P, Dubus P, Fricain JC.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Sep;116(3):e185-90. doi: 10.1016/j.oooo.2013.03.017. Epub 2013 May 10.

PMID:
23669204
50.

The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus.

Richez C, Richards RJ, Duffau P, Weitzner Z, Andry CD, Rifkin IR, Aprahamian T.

PLoS One. 2013;8(4):e61042. doi: 10.1371/journal.pone.0061042. Epub 2013 Apr 8.

Supplemental Content

Loading ...
Support Center